Altered interactions between unicellular and multicellular genes drive hallmarks of transformation in a diverse range of solid tumors

Significance Cancer represents a breakdown of molecular mechanisms evolved by multicellular life to impose constraints on cell growth, resulting in more “primitive” proliferative cellular phenotypes. This suggests interpreting the activity of genes in cancer according to their evolutionary origins may provide insights into common mechanisms driving tumorigenesis. We incorporated phylogenetic and interaction data into expression analysis of seven solid tumors, revealing universal strong preferential expression of genes shared with unicellular species in tumors, alongside widespread disruption of links between unicellular and multicellular components of gene regulatory networks. Considering how the constraints imposed on these networks by evolution were altered in tumors identified molecular processes that could be manipulated for therapeutic benefit in cancer and uncovered several promising drug targets. Tumors of distinct tissues of origin and genetic makeup display common hallmark cellular phenotypes, including sustained proliferation, suppression of cell death, and altered metabolism. These phenotypic commonalities have been proposed to stem from disruption of conserved regulatory mechanisms evolved during the transition to multicellularity to control fundamental cellular processes such as growth and replication. Dating the evolutionary emergence of human genes through phylostratigraphy uncovered close association between gene age and expression level in RNA sequencing data from The Cancer Genome Atlas for seven solid cancers. Genes conserved with unicellular organisms were strongly up-regulated, whereas genes of metazoan origin were primarily inactivated. These patterns were most consistent for processes known to be important in cancer, implicating both selection and active regulation during malignant transformation. The coordinated expression of strongly interacting multicellularity and unicellularity processes was lost in tumors. This separation of unicellular and multicellular functions appeared to be mediated by 12 highly connected genes, marking them as important general drivers of tumorigenesis. Our findings suggest common principles closely tied to the evolutionary history of genes underlie convergent changes at the cellular process level across a range of solid cancers. We propose altered activity of genes at the interfaces between multicellular and unicellular regions of human gene regulatory networks activate primitive transcriptional programs, driving common hallmark features of cancer. Manipulation of cross-talk between biological processes of different evolutionary origins may thus present powerful and broadly applicable treatment strategies for cancer.

[1]  Hanlee P. Ji,et al.  Pan-cancer analysis of the extent and consequences of intratumor heterogeneity , 2015, Nature Medicine.

[2]  Ellen Clarke Evolutionary Transitions to Multicellular Life , 2016 .

[3]  Jianzhi Zhang,et al.  Phylostratigraphic Bias Creates Spurious Patterns of Genome Evolution. , 2016, Molecular biology and evolution.

[4]  Xionglei He,et al.  The Convergent Cancer Evolution toward a Single Cellular Destination. , 2016, Molecular biology and evolution.

[5]  R. Pearson,et al.  Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma. , 2016, Cancer discovery.

[6]  J. Sturm,et al.  Ancient hot and cold genes and chemotherapy resistance emergence , 2015, Proceedings of the National Academy of Sciences.

[7]  Mel Greaves,et al.  Evolutionary determinants of cancer. , 2015, Cancer discovery.

[8]  M. Hochberg,et al.  Cancer across the tree of life: cooperation and cheating in multicellularity , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

[9]  Xionglei He,et al.  The reverse evolution from multicellularity to unicellularity during carcinogenesis , 2015, Nature Communications.

[10]  Juancarlos Chan,et al.  Gene Ontology Consortium: going forward , 2014, Nucleic Acids Res..

[11]  R. Solé,et al.  Evolutionary Transitions to Multicellular Life: Principles and mechanisms , 2015 .

[12]  Jianzhi Zhang,et al.  Phylostratigraphic bias creates spurious patterns of genome evolution. , 2015, Molecular biology and evolution.

[13]  C. Lineweaver,et al.  Targeting cancer's weaknesses (not its strengths): Therapeutic strategies suggested by the atavistic model , 2014, BioEssays : news and reviews in molecular, cellular and developmental biology.

[14]  B. Anokhin,et al.  Naturally occurring tumours in the basal metazoan Hydra , 2014, Nature Communications.

[15]  A. Cipponi,et al.  Stress‐induced cellular adaptive strategies: Ancient evolutionarily conserved programs as new anticancer therapeutic targets , 2014, BioEssays : news and reviews in molecular, cellular and developmental biology.

[16]  Robert A. Gatenby,et al.  Life history trade-offs in cancer evolution , 2013, Nature Reviews Cancer.

[17]  J. Thakar,et al.  Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations , 2013, Nucleic acids research.

[18]  Anirban P. Mitra,et al.  Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy , 2013, PloS one.

[19]  R. Nesse,et al.  Evolutionary foundations for cancer biology , 2013, Evolutionary applications.

[20]  J. Ricci,et al.  Glycolysis inhibition targets Mcl-1 to restore sensitivity of lymphoma cells to ABT-737-induced apoptosis , 2012, Leukemia.

[21]  M. Vincent Cancer: a de-repression of a default survival program common to all cells?: a life-history perspective on the nature of cancer. , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.

[22]  Robert H. Austin,et al.  An analogy between the evolution of drug resistance in bacterial communities and malignant tissues , 2011, Nature Reviews Cancer.

[23]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[24]  C. Lineweaver,et al.  Cancer tumors as Metazoa 1.0: tapping genes of ancient ancestors , 2011, Physical biology.

[25]  Gary D. Bader,et al.  Pathway Commons, a web resource for biological pathway data , 2010, Nucleic Acids Res..

[26]  D. Tautz,et al.  A phylogenetically based transcriptome age index mirrors ontogenetic divergence patterns , 2010, Nature.

[27]  Diethard Tautz,et al.  Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa , 2010, BMC Biology.

[28]  Ben S. Wittner,et al.  Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 , 2009, Nature.

[29]  Adam J Engler,et al.  Multiscale Modeling of Form and Function , 2009, Science.

[30]  Diethard Tautz,et al.  An Ancient Evolutionary Origin of Genes Associated with Human Genetic Diseases , 2008, Molecular biology and evolution.

[31]  Tomislav Domazet-Loso,et al.  A phylostratigraphy approach to uncover the genomic history of major adaptations in metazoan lineages. , 2007, Trends in genetics : TIG.

[32]  Mel Greaves,et al.  Darwinian medicine: a case for cancer , 2007, Nature Reviews Cancer.

[33]  C. Maley,et al.  Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .

[34]  Z. Szallasi,et al.  A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers , 2006, Nature Genetics.

[35]  C. Stoeckert,et al.  OrthoMCL: identification of ortholog groups for eukaryotic genomes. , 2003, Genome research.

[36]  A. Barabasi,et al.  Lethality and centrality in protein networks , 2001, Nature.

[37]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.